[A new antibiotic with antineoplastic activity: rubidomycin (13.057 R.P.). II. Experimental antitumor activity].
D000230:Adenocarcinoma / Q000188:drug therapy; D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology* / Q000627:therapeutic use*; D000917:Antibody Formation / Q000187:drug effects; D001201:Ascites / Q000188:drug therapy; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D002645:Chickens; D002875:Chromosomes / Q000187:drug effects; D046508:Culture Techniques; D004355:Drug Stability; D005260:Female; D006019:Glycolysis / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007938:Leukemia / Q000188:drug therapy; D007942:Leukemia, Experimental / Q000188:drug therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D051379:Mice; D008938:Mitosis / Q000187:drug effects; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D011817:Rabbits; D012119:Respiration / Q000187:drug effects; D012510:Sarcoma 180 / Q000188:drug therapy; D001357:Sarcoma, Avian / Q000188:drug therapy; D012513:Sarcoma, Experimental / Q000188:drug therapy; D014412:Tumor Virus Infections / Q000188:drug therapy
D000596:Amino Acids; D000903:Antibiotics, Antineoplastic; D007166:Immunosuppressive Agents
Un nouvel antibiotique doué d'activité antitumorale: la rubidomycine (13.057 R.P.). II: Activité antitumorale expérimentale.